Records containing: Hepatocarcinoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-30Evaluation of Skin Tests in Biotherapy Allergies
-
CLINICAL_TRIALS study record update · 2026-02-27Decoding Epigenetic Mechanisms Driving Immune Evasion in Liver Cancer With Omics Approaches
-
CLINICAL_TRIALS study record update · 2025-12-22Prediction of Decompensation and HCC Development in Patients With Advanced Chronic Liver Disease by the PLEASE and M10S20 Algorithms
-
CLINICAL_TRIALS study record update · 2025-03-28Icariin Soft Capsules Combined With TACE as Adjuvant Therapy for Hepatocellular Carcinoma With High-Risk Recurrence Factors:A Single-Center, Prospective Study
-
CLINICAL_TRIALS study record update · 2025-03-20Assessment of Hepatocarcinoma Innervation by Tissue Transparisation and Pharmacological Screening
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-06-25A Phase II/III Trial of Comparison of Benefit of Administration of Checkpoint Inhibitors Plus Chemodrug Via Artery or Fine Needle to Tumor Versus Vein for Immunotherapy of Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2024-05-31A Multicenter, Prospective Cohort Study Investigating Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local Ablation
-
CLINICAL_TRIALS study record update · 2024-02-07METabolic PROFILE of Hepatocarcinoma and Pancreatic Tumors
-
CLINICAL_TRIALS study record update · 2023-09-18A Randomized, Controlled, Open-label, Multi-center Clinical Trial of Multi-kinase Inhibitor Combined With Bevacizumab as Adjuvant Therapy in Patients With Hepatocellular Carcinoma and High-risk Recurrence Factors After Liver Transplantation
-
CLINICAL_TRIALS study record update · 2023-09-13A Prospective, Observational Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)
-
CLINICAL_TRIALS study record update · 2022-08-04Quality of Life After Hepatectomy for Primary Liver Tumors: a Prospective Randomized Clinical Trial on the Role of Supplemental Therapy With Synchrolevels
-
CLINICAL_TRIALS study record update · 2022-06-21A Sorafenib-Regorafenib Sequence Treatment Monitoring Study Using Liquid Biopsy
-
CLINICAL_TRIALS study record update · 2022-04-05Hepatic Artery Infusion Chemotherapy(HAIC) Combined With Anlotinib and TQB2450 as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Resection
-
CLINICAL_TRIALS study record update · 2022-02-01A Dose Escalation Phase I Study of LNA-i-miR-221 for the Treatment of Refractory Multiple Myeloma and Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2021-02-10Multicentric Study Determining the Benefit of the Use of 3D Models and Tools in Hepatectomy Planning for Hepatocarcinomas
-
CLINICAL_TRIALS study record update · 2020-10-01Diagnostic and Prognostic Role of 11C-Choline PET/CT and DWI MRI for Response Assessment in Patients Affected by Hepatocellular Carcinoma (HCC) and Candidate to TARE
-
CLINICAL_TRIALS study record update · 2020-06-17Efficacy and Safety of Cabozantinib in Patients With Hepatocellular Carcinoma Progressing on or Intolerant to Prior Treatment With Immune Checkpoint Inhibitors: A Phase II Study (Immunocabo)
-
CLINICAL_TRIALS study record update · 2019-01-24Essai Clinique Pour Une Endomicroscopie Robotisée Dans la redéfinition Des Stratégies d'ExérèsE (PERSÉE) appliquée à la Chirurgie Hépatique
-
CLINICAL_TRIALS study record update · 2014-12-10Assessment of Diffusion-weighted Magnetic Resonance (MR) Imaging to Predict Chemotherapy Outcome in Liver Metastases and Hepatocellular Carcinoma (HCC)